Form D · Biotechnology
Kilele Health Inc.
Oakwood, OH · CIK 0002087187
Offering snapshot reported Oct 1, 2025 · SEC filing
- Reported sold
- $265K Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $48K Reported outside-investor minimum
- First sale
- Sep 23, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2025 | Initial | $264,500 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-559399
Source: Form D, filed Oct 1, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brittany Nicole Arde | Executive |
| Andrew David Cothrel | Director, Executive, Promoter |
| Jason Charles Heikenfeld | Director, Executive, Promoter |
| Sven Schreiber | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
201 E. Dixon Ave
Oakwood, OH, 45419
Oakwood, OH, 45419